Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models (Q57515329)

https://api.crossref.org/works/10.1177%2F0272989X11409240

The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Characterizing structural uncertainty in decision analytic models: a review and application of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Structural and parameter uncertainty in Bayesian cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Accounting for uncertainty in health economic decision models by using model averaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Sensitivity analysis in cost-effectiveness studies: from guidelines to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

The combined analysis of uncertainty and patient heterogeneity in medical decision models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

A concise equation that captures the essential elements of one-way sensitivity analyses in health economic models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

The epidemiology of varicella and its complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Varicella vaccination in England and Wales: cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Economic evaluations of varicella vaccination programmes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Handling uncertainty in cost-effectiveness models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Saving future lives. A comparison of three discounting models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

The epidemiology of varicella–zoster virus infections: the influence of varicella on the prevalence of herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Bayesian calibration of a natural history model with application to a population model for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Calibrating models in economic evaluation: a seven-step approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Exploring uncertainty in cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Lessons from overviews of cardiovascular trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Correlations between parameters in risk models: estimation and propagation of uncertainty by Markov Chain Monte Carlo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Dynamic microsimulation models for health outcomes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Uncertainty and patient heterogeneity in medical decision models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Generalisability in economic evaluation studies in healthcare: a review and case studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240

Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11409240